K-numberK243956
Device nameTG-980P CO2 Sensor Kit (TG-980P); TG-980P1 CO2 Sensor Kit (TG-980P1)
ApplicantNihon Kohden Corporation
Product codeCCK
Device classClass II
Decision dateJun 10, 2025
DecisionSubstantially Equivalent
Regulation868.1400
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The TG-980P and TG-980P1 are CO2 sensor kits that measure carbon dioxide concentration in exhaled patient breath using mainstream infrared absorption. They are intended for use by qualified medical personnel in hospitals, ambulatory care, transport, and other clinical environments to aid in determining a patient's ventilatory status.

Technological characteristics

Both the subject device and predicate use mainstream infrared absorption with non-dispersive infrared (NDIR) single-wave spectroscopic measurement. The subject device has a faster response time (60 msec vs. 120 msec for EtCO2), can support both intubated and non-intubated patients (versus intubated only for the predicate), weighs less (65g vs. 120g), and has a simplified configuration without a separate CO2 adapter. The TG-980P1 variant includes a higher data sampling rate (62.5 Hz vs. 40 Hz) and shorter warm-up time (5 seconds vs. 10 seconds).

Test standards cited

IEC 60601-1 (general medical electrical equipment safety), ISO 80601-2-55 (respiratory gas monitors), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-1-12 (emergency medical services environment), ISO 10993-1 (biocompatibility), ISO 14971 (risk management), IEC 62366-1 (usability engineering), IEC 60601-1-6 (usability), IEC 62304 (software lifecycle), and ISO 17664-2 (reprocessing information).

Substantial equivalence argument

The subject device shares identical regulatory classification (Class II, 21 CFR 868.1400), intended use, and indications for use with the predicate TG-970P. Both employ the same measurement principle (mainstream NDIR spectroscopy) and achieve the same CO2 measurement specifications and accuracy. The dimensional and design changes (removal of CO2 adapter, lighter weight, faster response, extended patient population) represent improvements that do not compromise safety or effectiveness. Performance testing using identical test methods and specifications to the predicate establishes that these modifications do not raise concerns regarding safety and effectiveness.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →